DSIR Recognition to Venus Remedies' in-house R&D Unit

With the renewal of recognition from DSIR and its ongoing efforts to combat antimicrobial resistance, Venus Remedies Limited solidifies its position as a leading research-driven pharmaceutical company, dedicated to excellence in research and bringing innovative medical solutions to address global healthcare challenges, it said. "Our in-house R&D unit has been at the forefront of pioneering research and development initiatives," said Saransh Chaudhary, CEO of Venus Medicine Research Centre and President of Global Critical Care at Venus Remedies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VYAIoan
via IFTTT